Rare diseases
Investigational molecules
Locations
Back to Germany982 clinical trials in Stuttgart, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
GermanyImmunogenicity and safety of intradermal zoonotic influenza vaccine (H5N8) compared with intramuscular administration in adults 40–80 years with avian influenza
GermanyPhase 1/2 study of AVZO-023 drug combination in patients with advanced cancer
GermanyPhase 2 Study of Oral VS-7375 in Adults with Advanced KRAS G12D‑Mutated Non‑Small Cell Lung Cancer Previously Treated
GermanyPhase 1b study of empasiprubart in adults with multifocal motor neuropathy to assess nerve morphology by ultrasound
GermanyLong‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3
GermanyStudy of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy
GermanyStudy of setidegrasib (ASP3082) and docetaxel in patients with KRAS G12D‑mutated advanced/metastatic NSCLC after platinum chemo and checkpoint inhibitor
GermanyTislelizumab with drug combination in patients with PD-L1‑high metastatic non‑small cell lung cancer and high tumor burden
GermanyPembrolizumab alone versus pembrolizumab with chemotherapy drug combination in women with advanced non‑small cell lung cancer
GermanyA Study of ATSN-201 Gene Therapy for Patients with X-linked Retinoschisis (RS1-associated) to Assess Safety and Visual Function
GermanyEnhanced dual antiplatelet therapy with clopidogrel and acetylsalicylic acid for secondary prevention in patients with mild ischemic stroke
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic prostate cancer, diffuse large B-cell lymphoma, and bladder cancer treatments. Studies evaluate novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Several trials investigating breakthrough treatments for various forms of leukemia and solid tumors.
Research focusing on cytomegalovirus prevention and influenza vaccination in different age groups. Studies evaluate innovative vaccine formulations and immune responses.
Trials aim to enhance vaccine efficacy and improve protection against infectious diseases.
Studies addressing weight management and various eye conditions including retinal disorders. Research includes innovative treatments for macular degeneration and vision preservation.
Focus on developing treatments that improve patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
